Summit Therapeutics PLC (SMMT) — Net Asset Quality Index
Summit Therapeutics PLC (SMMT) has a Net Asset Quality Index of 83.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $752.18 Million minus total liabilities of $122.20 Million yields net assets of $629.98 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Summit Therapeutics PLC debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Summit Therapeutics PLC Net Asset Quality Index Over Time (2003–2025)
This chart shows how Summit Therapeutics PLC's Net Asset Quality Index has evolved across 23 annual periods from 2003 to 2025. As of June 2026, the index stands at 83.8%, representing net assets of $629.98 Million against total assets of $752.18 Million USD. For live market cap and overall valuation, see market cap of Summit Therapeutics PLC.
Annual Net Asset Quality Index for Summit Therapeutics PLC (2003–2025)
The table below presents the year-by-year Net Asset Quality Index for Summit Therapeutics PLC from 2003 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Summit Therapeutics PLC to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.7% | $488.98 Million | $557.50 Million | $68.52 Million | ▼ -1.5 pp |
| 2024 | 89.3% | $310.64 Million | $348.05 Million | $37.41 Million | ▲ +51.0 pp |
| 2023 | 38.3% | $61.48 Million | $160.60 Million | $99.12 Million | ▲ +19.2 pp |
| 2022 | 19.1% | $103.25 Million | $541.43 Million | $438.18 Million | ▼ -54.4 pp |
| 2021 | 73.5% | $61.74 Million | $84.04 Million | $22.30 Million | ▼ -4.1 pp |
| 2020 | 77.5% | $58.36 Million | $75.29 Million | $16.93 Million | ▼ -3.5 pp |
| 2019 | 81.0% | $61.12 Million | $75.46 Million | $14.34 Million | ▲ +10.8 pp |
| 2018 | 70.2% | $55.79 Million | $79.53 Million | $23.74 Million | ▲ +51.9 pp |
| 2017 | 18.3% | $13.98 Million | $76.38 Million | $62.40 Million | ▲ +27.6 pp |
| 2016 | -9.3% | $-4.37 Million | $46.98 Million | $51.35 Million | ▼ -93.6 pp |
| 2015 | 84.3% | $30.10 Million | $35.71 Million | $5.62 Million | ▲ +17.4 pp |
| 2014 | 66.8% | $19.53 Million | $29.22 Million | $9.69 Million | ▲ +1.6 pp |
| 2013 | 65.3% | $7.85 Million | $12.03 Million | $4.18 Million | ▲ +0.1 pp |
| 2012 | 65.1% | $4.50 Million | $6.91 Million | $2.41 Million | ▲ +3.4 pp |
| 2011 | 61.8% | $3.78 Million | $6.12 Million | $2.34 Million | ▼ -10.5 pp |
| 2010 | 72.2% | $5.82 Million | $8.06 Million | $2.24 Million | ▲ +0.3 pp |
| 2009 | 72.0% | $13.22 Million | $18.38 Million | $5.15 Million | ▲ +10.6 pp |
| 2008 | 61.3% | $12.33 Million | $20.09 Million | $7.77 Million | ▼ -16.6 pp |
| 2007 | 77.9% | $54.08 Million | $69.38 Million | $15.30 Million | ▼ -8.4 pp |
| 2006 | 86.4% | $40.11 Million | $46.44 Million | $6.33 Million | ▼ -4.0 pp |
| 2005 | 90.4% | $23.38 Million | $25.87 Million | $2.49 Million | ▼ -8.3 pp |
| 2004 | 98.7% | $26.53 Million | $26.88 Million | $350.21K | ▲ +1.2 pp |
| 2003 | 97.5% | $142.31K | $145.96K | $3.65K | — |